JPS6326089B2 - - Google Patents

Info

Publication number
JPS6326089B2
JPS6326089B2 JP54044270A JP4427079A JPS6326089B2 JP S6326089 B2 JPS6326089 B2 JP S6326089B2 JP 54044270 A JP54044270 A JP 54044270A JP 4427079 A JP4427079 A JP 4427079A JP S6326089 B2 JPS6326089 B2 JP S6326089B2
Authority
JP
Japan
Prior art keywords
filter
blood cells
leukocytes
white blood
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP54044270A
Other languages
Japanese (ja)
Other versions
JPS55136955A (en
Inventor
Tooru Kuroda
Nobuaki Tsuda
Yoshinori Takenaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Chemical Industry Co Ltd
Original Assignee
Asahi Chemical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Industry Co Ltd filed Critical Asahi Chemical Industry Co Ltd
Priority to JP4427079A priority Critical patent/JPS55136955A/en
Publication of JPS55136955A publication Critical patent/JPS55136955A/en
Publication of JPS6326089B2 publication Critical patent/JPS6326089B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Description

【発明の詳細な説明】 本発明は白血球の捕捉・採取用フイルターに関
する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a filter for capturing and collecting leukocytes.

更に詳しく述べると、血液、体液またはこれら
を処理して得られる血球浮遊液から白血球を簡単
な操作で短時間に捕捉・採取できるフイルターに
関するものである。
More specifically, the present invention relates to a filter that can capture and collect white blood cells from blood, body fluids, or a blood cell suspension obtained by processing these in a short time with simple operations.

近年、血液学、免疫学の進歩に伴ない、従来の
全血輸血に代わる血液の成分輸血、白血球の機能
検査、白血球の表面抗原の検査等を行ない各種疾
患の治療、診断等に応用することが各地の病院、
研究機関で行なわれている。
In recent years, with advances in hematology and immunology, transfusion of blood components instead of conventional whole blood transfusion, functional tests of leukocytes, and tests of surface antigens of leukocytes have been carried out, and applied to the treatment and diagnosis of various diseases. are hospitals in various places,
It is carried out at a research institution.

この様な目的に使用可能な従来の白血球の捕
捉、採取技術としては、赤血球凝集剤を用いる方
法、遠心分離法、血球の繊維への粘着力を利用す
る方法等がある。
Conventional leukocyte capture and collection techniques that can be used for such purposes include methods using red blood cell agglutinants, centrifugation, and methods that utilize the adhesive force of blood cells to fibers.

更に詳しく述べると、赤血球凝集剤を用いる方
法は血液にデキストランやヒドロキシエチルスタ
ーチなどの赤血球凝集剤を加え、一定時間放置後
に白血球に富んだ上清を得る方法であり、遠心分
離方法は血液を遠心分離して白血球に富むバツフ
イーコートを採取する方法、比重1.077の液体に
血液を重層後、遠心分離を行ないリンパ球層を回
収する密度勾配遠心分離方法等である。繊維への
粘着力を利用する既知の方法は繊維に単球・顆粒
球を付着させ、生理食塩水、リン酸緩衝生理食塩
水等により付着した血球を回収する方法、凝集剤
や遠心分離の使用により白血球に富む分画を得、
その後この白血球分画をナイロン、ガラスウール
等の繊維を詰めたカラムに入れ、37℃に保温し30
分位放置した後リンパ球を回収する方法である。
More specifically, the method using a hemagglutinating agent involves adding a hemagglutinating agent such as dextran or hydroxyethyl starch to the blood, and then leaving it for a certain period of time to obtain a supernatant rich in white blood cells.The centrifuging method involves centrifuging the blood. There are two methods: a method in which blood is separated and a buffer coat rich in white blood cells is collected, and a density gradient centrifugation method in which blood is layered in a liquid with a specific gravity of 1.077 and then centrifuged to collect a lymphocyte layer. Known methods that utilize adhesion to fibers include attaching monocytes and granulocytes to fibers and collecting the attached blood cells using physiological saline, phosphate buffered saline, etc., and using a flocculant or centrifugation. A leukocyte-rich fraction was obtained by
Then, this white blood cell fraction was placed in a column packed with fibers such as nylon or glass wool, and kept at 37℃ for 30 minutes.
This is a method in which lymphocytes are collected after being left in a portion.

しかし、これらの方法には次の様な欠点があつ
た。すなわち、赤血球凝集剤を用いる方法は比較
的簡便な操作により白血球の浮遊液が得られる
が、この浮遊液には、白血球の数倍の赤血球、数
十倍の血小板及び多量の血漿と赤血球凝集剤が含
まれており、輸血用にはもちろんのこと、検査用
としても、そのまま白血球浮遊液として使えるも
のではなかつた。実際に使用できる状態の白血球
浮遊液にする為には、数回の洗浄操作や混入不純
物除去の為の様々な操作が必要であり、結局、多
大な時間と手間がかかつてしまう。遠心分離法
は、輸血用に必要な血液量を処理する為には大型
の遠心分離器が必要であり、検査用程度の少量の
血液を処理するだけでも、かなり高価な遠心分離
器が必要となる。また、得られた白血球中の不純
物を除去する為には更に数回の遠心分離操作を必
要とし、これらの操作を行なう際、一部の白血球
は破壊され、白血球の回収率が悪くなつてしま
う。更に、非常に煩雑な操作である為、無菌的な
操作が難しく、熟練者でも多大な労力と時間を必
要とした。繊維への血球の粘着力を利用する従来
の方法は、一般にリンパ球の繊維への粘着能が弱
い為白血球全体を一度に分離することはできなか
つた。
However, these methods had the following drawbacks. In other words, the method using a hemagglutinating agent allows a suspension of white blood cells to be obtained through a relatively simple operation, but this suspension contains several times as many red blood cells as white blood cells, several tens of times as many platelets, and a large amount of plasma as well as the hemagglutinating agent. It could not be used directly as a white blood cell suspension, let alone for blood transfusions or for testing purposes. In order to obtain a leukocyte suspension in a condition that can actually be used, several washing operations and various operations for removing mixed impurities are required, which ultimately takes a lot of time and effort. The centrifugation method requires a large centrifuge to process the amount of blood required for transfusion, and a fairly expensive centrifuge is required even to process a small amount of blood for testing. Become. In addition, several more centrifugation operations are required to remove impurities from the obtained leukocytes, and when these operations are performed, some leukocytes are destroyed, resulting in a poor recovery rate of leukocytes. . Furthermore, since it is a very complicated operation, it is difficult to operate aseptically, and even an experienced person requires a great deal of labor and time. Conventional methods that utilize the adhesion of blood cells to fibers have generally been unable to separate all leukocytes at once because the adhesion of lymphocytes to fibers is weak.

そこで我々は、血液から簡単な操作で、純度、
収率良く白血球を捕捉、採取することを目的に鋭
意研究した結果、平均孔径が5から20μmの多孔
質フイルターが白血球を良く捕捉し、捕捉された
白血球の回収も簡単な操作で行なえることを見出
し本発明を得るに至つた。
Therefore, we can improve the purity and purity of blood with simple operations.
As a result of intensive research aimed at capturing and collecting leukocytes with a high yield, we found that a porous filter with an average pore diameter of 5 to 20 μm captures leukocytes well, and that the captured leukocytes can be recovered with simple operations. Heading This has led to the present invention.

すなわち本発明は、平均孔径が5から20μmの
連続細孔を有する多孔質フイルターを主要部とす
る白血球の捕捉、採取用フイルターである。
That is, the present invention is a filter for trapping and collecting white blood cells, the main part of which is a porous filter having continuous pores with an average pore diameter of 5 to 20 μm.

ここで、多孔質フイルターの材質は血球にダメ
ージを与えにくいものであれば何でも使えるが、
合成ゴム、合成樹脂の発泡体等が孔径を調節し易
く使い易い。
Any material can be used for the porous filter as long as it does not cause damage to blood cells.
Synthetic rubber, synthetic resin foam, etc. are easy to use as the pore diameter can be easily adjusted.

以下図面を用いて本発明を説明する。第1図
は、本発明に用いる多孔質フイルターの断面の模
式図である。本発明で言う多孔質フイルターと
は、第1図の様に細孔1がランダムに開いてい
て、その細孔が多孔質構造物2の表面から他の表
面まで連続している物を言い、多孔質と言つても
必ずしもフレキシブルである必要は無い。平均孔
径とは、多孔質フイルターを任意に切断し断面全
体に分散している細孔の各々について直径を測定
して直径と細孔の数との関係を調べたときに、最
も数の多い細孔の円に換算した直径を表わすもの
である。すなわち、多孔質フイルターの任意の切
断面に分散する細孔はいろいろな形で、その直径
もさまざまであるが、個々の細孔をその細孔の断
面積と同じ面積の円に換算し、その直径を横軸に
とり、縦軸に細孔の数をとつてグラフを描くと一
般に正規分布に近い曲線となる。このとき細孔は
ランダムに1000個以上数えるのが好ましい。そし
て、その曲線のピークに当る直径が本発明で言う
平均孔径である。従つて多孔質フイルターに様々
な粒子を通した時に多孔質フイルターの平均直径
以上の直径の粒子は通過し難いという径を表わす
ものであつて、これ以上の直径の粒子は絶体に通
過しないというものでは無い。
The present invention will be explained below using the drawings. FIG. 1 is a schematic cross-sectional view of a porous filter used in the present invention. The porous filter used in the present invention refers to a filter in which the pores 1 are randomly opened as shown in FIG. 1, and the pores are continuous from the surface of the porous structure 2 to other surfaces. Even though it is porous, it does not necessarily have to be flexible. The average pore diameter is the number of pores with the largest number when cutting a porous filter arbitrarily and measuring the diameter of each pore dispersed throughout the cross section to examine the relationship between the diameter and the number of pores. It represents the diameter of the hole converted into a circle. In other words, the pores dispersed on any cut surface of a porous filter have various shapes and diameters, but each pore is converted into a circle with the same area as the cross-sectional area of the pore, and the If you draw a graph with the diameter on the horizontal axis and the number of pores on the vertical axis, you will generally get a curve close to a normal distribution. At this time, it is preferable to randomly count 1000 or more pores. The diameter corresponding to the peak of the curve is the average pore diameter in the present invention. Therefore, when various particles are passed through a porous filter, particles with a diameter larger than the average diameter of the porous filter are difficult to pass through, and particles with a larger diameter absolutely do not pass through. It's nothing.

また、多孔質フイルターは、多孔質構造物に比
べて細孔の空隙率が高い事が望ましく、細孔の孔
径分布も狭い方が望ましい。
Further, it is desirable that the porous filter has a higher pore porosity than a porous structure, and it is also desirable that the pore size distribution of the pores be narrower.

以下、例を上げて本発明白血球の捕捉・採取用
フイルターを説明する。第2図は本発明白血球の
捕捉、採取用フイルターの一例を示す模式図であ
り、第3図は本発明白血球の捕捉・採取用フイル
ターを使用する際の装置の一例を示す模式図であ
る。
Hereinafter, the filter for capturing and collecting clear blood cells of the present invention will be explained using an example. FIG. 2 is a schematic diagram showing an example of a filter for capturing and collecting clear blood cells of the present invention, and FIG. 3 is a schematic diagram showing an example of an apparatus when using the filter for capturing and collecting clear blood cells of the present invention.

本発明白血球の捕捉・採取用フイルターは例え
ば第2図の様に入口3、出口4を持つ容器5内に
多孔質フイルター6が収容されて構成される。こ
のフイルターを実際に使用する際には例えば第3
図の様な実験装置が用いられる。血液から白血球
を採取する実験を例にとつて説明すると、先ず血
液7はポンプ8により白血球の捕捉・採取用のフ
イルター9に送られ、ここで白血球が捕捉され、
赤血球、血漿等はフイルター9では捕捉されずに
容器10に送られる。
The filter for trapping and collecting blood cells of the present invention is constructed by housing a porous filter 6 in a container 5 having an inlet 3 and an outlet 4, as shown in FIG. 2, for example. When actually using this filter, for example,
The experimental equipment shown in the figure is used. Taking as an example an experiment in which leukocytes are collected from blood, blood 7 is first sent by a pump 8 to a filter 9 for capturing and collecting leukocytes, where the leukocytes are captured.
Red blood cells, plasma, etc. are not captured by the filter 9 and are sent to the container 10.

フイルター9で白血球が選択的に捕捉される理
由は白血球の粘着性によるものと、細孔による
過の2種類によるもので、赤血球は粘着能が低い
事と変形能が高いことから、このフイルター9に
は殆んど捕捉されない。また、白血球の粘着性と
細孔による過の2種類によつて白血球を捕捉し
ている為、一般のメンブレンフイルターによくみ
られる目詰まりを起こすことが非常に少なく、ま
た、白血球の粘着性だけを利用するフイルターの
様にリンパ球が多量に洩れ出してしまうことも殆
んど無い。
There are two reasons why white blood cells are selectively captured by the filter 9: one is due to the adhesiveness of the white blood cells, and the other is due to the pores. is hardly captured. In addition, because white blood cells are captured using two types of adhesion and pore filtration, there is very little chance of clogging, which is common in general membrane filters. There is almost no chance of large amounts of lymphocytes leaking out, unlike with filters that use filters.

次に容器11内の血液7が空になつた時点で血
液の導入管12を洗浄液13に入れ、フイルター
9内に残存する赤血球、血漿等を洗い流してや
り、その後フイルター9内に捕捉された白血球を
適当な方法で回収してやることにより、白血球が
純度、収率良く採取される。ここで洗浄液13
は、生理食塩水、リン酸緩衝生理食塩水等で良
い。また、血液7の代わりに何らかの方法で単
球・顆粒球を除去した血液を用いれば、フイルタ
ー9に捕捉される血球はリンパ球のみであり、リ
ンパ球が純度収率良く採取できることは言うまで
も無い。
Next, when the blood 7 in the container 11 is emptied, the blood introduction tube 12 is placed in the washing liquid 13 to wash away the red blood cells, plasma, etc. remaining in the filter 9, and then the white blood cells trapped in the filter 9 are washed away. By collecting the white blood cells using an appropriate method, white blood cells can be collected with high purity and high yield. Here, cleaning liquid 13
may be physiological saline, phosphate buffered saline, etc. Furthermore, if blood from which monocytes and granulocytes have been removed by some method is used instead of blood 7, the only blood cells captured by the filter 9 will be lymphocytes, and it goes without saying that lymphocytes can be collected with high purity and high yield. None.

この様に本発明白血球の捕捉・回収用フイルタ
ーを使用することにより、簡単な操作で、短時間
のうちに、純度、収率良く白血球を捕捉・採取す
ることができる様になつた。
As described above, by using the filter for capturing and collecting leukocytes of the present invention, it has become possible to capture and collect leukocytes with high purity and high yield in a short time with simple operations.

ここで、多孔質フイルターの平均孔径は5から
20μmの範囲であり、白血球の純度・収率の両面
からみて、10〜15μmが好ましい。平均孔径が5μ
m以下になると、フイルターに残存する赤血球が
急激に増えて来るとともにフイルターが目詰まり
を起こし易くなり、事実上、白血球の捕捉・採取
を目的とするフイルターとして使い難くなつてし
まい、また平均孔径が20μmを越えると、今度は
粘着能が低いリンパ球がフイルターから洩れ易く
なつてしまい、白血球全体を捕捉・回収するのが
難かしくなつてしまう。
Here, the average pore diameter of the porous filter is from 5 to
The diameter is in the range of 20 μm, and from the viewpoint of both purity and yield of white blood cells, 10 to 15 μm is preferable. Average pore size is 5μ
m or less, the number of red blood cells remaining in the filter increases rapidly and the filter becomes easily clogged, making it difficult to use as a filter for capturing and collecting white blood cells, and the average pore size increases. If the diameter exceeds 20 μm, lymphocytes with low adhesion will easily leak out of the filter, making it difficult to capture and collect all white blood cells.

尚、多孔質フイルターの細孔孔径の不均一性に
起因する捕捉したい血球の洩れ過ぎを防ぐ為、多
孔質フイルターの厚み、すなわち、多孔質フイル
ターの血液の入口から出口までの直線距離を10mm
以上とする。
In addition, in order to prevent excessive leakage of blood cells to be captured due to non-uniformity of the pore diameter of the porous filter, the thickness of the porous filter, that is, the linear distance from the blood inlet to the outlet of the porous filter, is set to 10 mm.
The above shall apply.

実施例 1 平均孔径が15μmのポリエステル発泡体を内径
20mm、長さ100mmの容器に入れて、白血球の捕
捉・採取用のフイルターとして用いた。また実験
装置としては第3図に示すものを用いた。このフ
イルターに健康人のヘパリン加血液50mlを5ml/
minの流速で流し、次に生理食塩水を同じ流速で
流して血液を洗浄し、合計150mlの液を得た。
この液には白血球はもとの血液の7%しか含ま
れていなかつたが赤血球は99.7%含まれていた。
この後フイルターに血漿を含む生理的溶液50mlを
流速5ml/minの流速で流し、フイルターに振動
を与えながら、フイルター内の白血球を回収し
た。回収した液を調べたところ、白血球はもとの
血液の55%が回収されており、赤血球は0.2%、
血小板は7%であつた。
Example 1 Polyester foam with an average pore size of 15 μm was
It was placed in a 20 mm x 100 mm long container and used as a filter for capturing and collecting leukocytes. The experimental apparatus shown in FIG. 3 was used. Add 50ml of heparinized blood from a healthy person to this filter.
The blood was washed away by flowing physiological saline at the same flow rate to obtain a total of 150 ml of liquid.
This fluid contained only 7% of the original blood white blood cells, but 99.7% red blood cells.
Thereafter, 50 ml of a physiological solution containing plasma was flowed through the filter at a flow rate of 5 ml/min, and the white blood cells in the filter were collected while vibrating the filter. When we examined the collected fluid, we found that 55% of the white blood cells were recovered, 0.2% of the red blood cells, and 0.2% of the red blood cells.
Platelet count was 7%.

実施例 2 平均孔径が10μmのポリエーテルウレタン発泡
材を内径10mm、長さ25mmの容器に入れて白血球の
捕捉・採取用フイルターとして用いた。このフイ
ルターに健康人のヘパリン加血液からポリアミド
繊維により、単球・顆粒球のほとんどを除いた血
液(白血球中のリンパ球の比率は95%であつた)
2mlを流速4mlで流し、その後15mlの生理食塩水
を同じ流速で流し、フイルター内の赤血球を洗浄
した。この後、フイルターに2mlの生理食塩水を
急速に流し、フイルター内の白血球を回収した。
回収した液を検査したところ、白血球中のリンパ
球の比率は95%、すなわち、純度95%のリンパ球
が単球、顆粒球のほとんどを除いた血液に対して
60%の回収率で得られた。また、このときの混入
赤血球はもとの血液に対して0.5%、混入血小板
は0.8%であつた。
Example 2 A polyether urethane foam material with an average pore diameter of 10 μm was placed in a container with an inner diameter of 10 mm and a length of 25 mm and used as a filter for capturing and collecting leukocytes. This filter was used to remove most of the monocytes and granulocytes from the heparinized blood of healthy people using polyamide fibers (the ratio of lymphocytes in white blood cells was 95%).
2 ml was flowed at a flow rate of 4 ml, and then 15 ml of physiological saline was flowed at the same flow rate to wash the red blood cells in the filter. Thereafter, 2 ml of physiological saline was rapidly poured into the filter, and the white blood cells in the filter were collected.
When the collected fluid was tested, the ratio of lymphocytes in white blood cells was 95%, that is, 95% pure lymphocytes compared to blood excluding most of monocytes and granulocytes.
A recovery rate of 60% was obtained. Furthermore, the amount of contaminated red blood cells at this time was 0.5% of the original blood, and the amount of mixed platelets was 0.8%.

以上述べた様に、本発明白血球の捕捉・採取用
フイルターを用いる事により、簡便な操作で、短
時間のうちに、純度、収率ともに良く白血球を捕
捉・採取できる様になつた。また、本発明白血球
捕捉・採取用フイルターは密閉回路を構成するこ
とが容易で無菌的操作も非常に簡便になつた。
As described above, by using the filter for capturing and collecting leukocytes of the present invention, it has become possible to capture and collect leukocytes with good purity and yield in a short time with simple operations. In addition, the filter for capturing and collecting clear blood cells of the present invention can easily form a sealed circuit, making aseptic operation extremely simple.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は本発明における多孔質フイルターの断
面の模式図であり第2図は本発明白血球の捕捉・
採取用フイルターの一例を示す模式図であり、第
3図は本発明白血球の捕捉・採取用フイルターを
使用する際の装置の一例を示す模式図である。 1……細孔、2……多孔質構造物、3……入
口、4……出口、5,10,11……容器、6…
…多孔質フイルター、7……血液、8……ポン
プ、9……白血球の捕捉・採取用フイルター、1
2……血液の導入管、13……洗浄液。
FIG. 1 is a schematic cross-sectional view of the porous filter of the present invention, and FIG. 2 is a cross-sectional view of the porous filter of the present invention.
FIG. 3 is a schematic diagram showing an example of a collection filter, and FIG. 3 is a schematic diagram showing an example of an apparatus when using the clear blood cell capture/collection filter of the present invention. 1... Pore, 2... Porous structure, 3... Inlet, 4... Outlet, 5, 10, 11... Container, 6...
... Porous filter, 7 ... Blood, 8 ... Pump, 9 ... Filter for capturing and collecting white blood cells, 1
2...Blood introduction tube, 13...Washing liquid.

Claims (1)

【特許請求の範囲】 1 平均孔径が5から20ミクロンメートル(μ
m)の連続細孔を有する多孔質フイルターを主要
部とする白血球の捕捉・採取用フイルター。 2 多孔質フイルターの厚みが10mm以上である特
許請求の範囲第1項記載の白血球の捕捉・採取用
フイルター。
[Claims] 1. The average pore diameter is from 5 to 20 micrometers (μ
m) A filter for capturing and collecting white blood cells, the main part of which is a porous filter having continuous pores. 2. The filter for capturing and collecting white blood cells according to claim 1, wherein the porous filter has a thickness of 10 mm or more.
JP4427079A 1979-04-13 1979-04-13 Filter for catching and gathering leucocyte Granted JPS55136955A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4427079A JPS55136955A (en) 1979-04-13 1979-04-13 Filter for catching and gathering leucocyte

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4427079A JPS55136955A (en) 1979-04-13 1979-04-13 Filter for catching and gathering leucocyte

Publications (2)

Publication Number Publication Date
JPS55136955A JPS55136955A (en) 1980-10-25
JPS6326089B2 true JPS6326089B2 (en) 1988-05-27

Family

ID=12686815

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4427079A Granted JPS55136955A (en) 1979-04-13 1979-04-13 Filter for catching and gathering leucocyte

Country Status (1)

Country Link
JP (1) JPS55136955A (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6475015A (en) * 1987-09-18 1989-03-20 Terumo Corp Filter for separating leukocytes
JPS6475014A (en) * 1987-09-18 1989-03-20 Terumo Corp Filter for separating leukocytes
IL88081A0 (en) * 1987-10-20 1989-06-30 Pall Corp Device and method for depletion of the leucocyte content of blood and blood components
US7169547B2 (en) 1994-12-05 2007-01-30 New York Blood Center, Inc. High concentration white blood cells as a therapeutic product
IL137077A (en) 2000-06-28 2003-05-29 Teva Medical Ltd Leukoreduction filter

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3765536A (en) * 1970-11-10 1973-10-16 Pall Corp Blood filter cascade
JPS5444007A (en) * 1977-09-12 1979-04-07 Asahi Chem Ind Co Ltd Heamtocyte separator
JPS5444005A (en) * 1977-09-12 1979-04-07 Asahi Chem Ind Co Ltd Separation of leucocyte

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3765536A (en) * 1970-11-10 1973-10-16 Pall Corp Blood filter cascade
JPS5444007A (en) * 1977-09-12 1979-04-07 Asahi Chem Ind Co Ltd Heamtocyte separator
JPS5444005A (en) * 1977-09-12 1979-04-07 Asahi Chem Ind Co Ltd Separation of leucocyte

Also Published As

Publication number Publication date
JPS55136955A (en) 1980-10-25

Similar Documents

Publication Publication Date Title
JPS603367B2 (en) Leukocyte separation method and leukocyte separation material
JPH03173825A (en) Filter for purifying blood platelet
JPH0651063B2 (en) How to selectively remove white blood cells
JP6707031B2 (en) Cell separation material and cell separation method
JPH0213588B2 (en)
JPH01320064A (en) Blood component separating system
JPH05317413A (en) Sampler for blood component removed leukocyte
JPH0534337A (en) Filter for separating leucocyte
JP2013036818A (en) Method of concentrating tumor cell and separation material
JPS6326089B2 (en)
WO1989002304A1 (en) Leucocyte-separating filter
JP2012139112A (en) Differential leukocyte count recovery unit
JPS6324975B2 (en)
JP2001000178A (en) Method and apparatus for cell separation
JPS5854130B2 (en) Leukocyte separation method
JPS6139060B2 (en)
JPH0614968B2 (en) Leukocyte capture and separation device
JP4437335B2 (en) Human undifferentiated hematopoietic stem cells, separation method and separation apparatus thereof
JPS5854128B2 (en) Lymphocyte isolation method and device
JPH04329965A (en) Selective removal method of leukocyte
JPH11290060A (en) Cell separation filter suitable for recovering cell, cell separation system and separation of cell
JPS5936886B2 (en) How to isolate white blood cells
JPS5854125B2 (en) Leukocyte separation filter and leukocyte separation method
JPS5854129B2 (en) Lymphocyte separation method
JP4043094B2 (en) Cell separator